Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Molecular Epidemiology Study in Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) of Adeno Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status

NCT01185314 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01185314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01185314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Molecular Epidemiology Study in Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) of Adeno Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status
Lead sponsor
AstraZeneca
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2010
Completion date
July 31, 2011
Enrollment
1,270 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer